EC Gynaecology

Introduction: Mastectomy has been a treatment for early stage of the breast cancer for a very long time with all the consequences that have both physical and mental consequences. Several trials have since validated the efficacy of the treatment of early-stage breast cancers demonstrating an equivalence in terms of overall survival between mastectomy-auxiliary dissection without radiotherapy and conservative treatment with radiotherapy.

Objective: The objective is to report the results obtained and analyze them on an epidemiological, clinical, Para clinical, anatomy-pathological and therapeutic level with the aim of establishing the profile of this cancer in the female population, which may benefits from conservative treatment.

Materials and Methods: We present in this work the experience of our team in conservative breast surgery. Longitudinal retrospective study, over a period of 04 years. We included all the patients having benefited from treatment for a malignant breast tumor within gynecology-obstetrics department as well as the medical oncology and radiotherapy department of HMIMV (Military Hospital) at Rabat.

Results: During this period of 04 years from January 2017 to December 2020, 345 women reached breast cancer, resented in the service of the GOB. Among them 200 women, benefiting from a conservative treatment is a time of 57.9%.

The initial indications for conservative treatment were limited to tumors of less than three centimeters, uni-focal, non-inflammatory.

The use of preoperative treatment (chemotherapy, radiotherapy, hormonal therapy) makes it possible to extend the indications for conservative treatment to larger tumors, and our approach consists in making enlarged surgical excesses while preserving the breast (oncoplastic surgery, sentinel node technique).

Conclusion: Surgery for breast cancer strives to reduce iatrogenic sequelae. This is how new therapeutic approaches are developed, oncoplastic surgery, sentinel lymph node technique and steriotaxic surgery.

Keywords: Conservative Treatment; Oncoplasty; Sentinel Node; Breast Cancer

1. Bray F., et al. “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries”. CA: A Cancer Journal for Clinicians 6 (2020): 394-424.
2. Fredholm H. “Breast cancer in young women: aspects on mortality and local recurrence” (2017).
3. Ferlay J., et al. GLOBOCAN 2019 v1. 0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 Internet. Lyon: IARC (2020).
4. Biglia N. Oncohighlight 2019, cancer incidence by sex 2019.
5. Benider A., et al. “Registry of cancers in the greater Casablanca region for the period 2004-2020”.
6. Lewis DR., et al. “Early estimates of SEER cancer incidence, 2014: SEER Cancer Incidence Estimates, 2014”. Cancer13 (2017): 2524‑2534.
7. Nkondjock A and Ghadirian P. “Breast cancer risk factors”. Medicine/Science 2 (2019): 175‑180.
8. Van den Brandt PA., et al. “Pooled analysis of prospective cohort studies on height, weight and breast cancer risk”. American Journal of Epidemiology 6 (2000): 514-527.
9. Wiren S., et al. “Pooled cohort study on height and risk of cancer and cancer death”. Cancer Causes and Control2 (2014): 151-159.
10. Unar-Munguía M., et al. “Breastfeeding Mode and Risk of Breast Cancer: A Dose-Response Meta-Analysis”. Journal of Human Lactation 2 (2017): 422-434.
11. Vatten LJ., et al. “Size at birth and risk of breast cancer: prospective population based study”. International Journal of Cancer 3 (2005): 461-464.
12. Tokunaga M., et al. “Incidence of female Breast cancer among atomic bomb survivors, 1950-1985”. Radiation Research 2 (1994): 209-223.
13. Pourcel G and Bousquet P-J. “Study on delays in treatment of breast and lung cancers”.
14. Benbakhta B., et al. “Determinants of patient and healthcare system delays for women with breast cancer in Morocco, 2013”. Revue d'Épidémiologie et de Santé Publique 3 (2015): 191-201.
15. Doridot V and Clough K. “Breast cancers: Epidemiology, pathological anatomy, screening, diagnosis, evolution, principles of treatment”. Revue du Praticien (2001): 1239‑12
16. Benoit L., et al. “Role of microbiopsy in diagnostic and therapeutic approach of suspected mammary microcalcification”. Annales de Chirurgie 6 (2003): 368‑372.
17. Dahlstrom JE., et al. “Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions”. Histopathology6 (1996): 537‑541.
18. Helbich TH., et al. “Stereotactic and ultrasound-guided breast biopsy”. European Radiology 3 (2004): 383-393.